Technical Analysis for ABVC - American Brivision (Holding) Corp

Grade Last Price % Change Price Change
grade D 7.6 -4.64% -0.3700
ABVC closed down 4.64 percent on Friday, September 20, 2019, on 2.53 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ABVC trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Gilligan's Island Buy Setup Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Doji - Bullish? Reversal 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

Older signals for ABVC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company's licensed products include ABV-1501, a combination therapy for triple negative breast cancer; ABV-1502, a combination therapy for solid tumors with Anti-PD1; ABV-1503, a combination therapy for chronic lymphocytic leukemia; ABV-1504 for depressive disorders; ABV-1505, a combination therapy for attention deficit hyperactivity disorder; BFC-1401, a vitreous substitute for vitrectomy; and Maitake combination therapy. It has a co-development agreement with Rgene Corporation to develop Maitake combination therapy products, such as ABV-1507 HER2/neu positive breast cancer combination therapy, ABV-1511 pancreatic cancer combination therapy, and ABV-1527 ovary cancer combination therapy; and collaborative agreements with BioLite Inc and BioFirst Corporation. The company was founded in 2015 and is based in Goshen, New York. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.
Health RTT Cancer Biopharmaceutical Drug Discovery Solid Tumors Therapy Breast Cancer Cancer Treatments Medicinal Chemistry Stage Biopharmaceutical Pancreatic Cancer Attention Deficit Hyperactivity Disorder Triple Negative Breast Cancer Depressive Disorders
Is ABVC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 15.0
52 Week Low 1.25
Average Volume 908
200-Day Moving Average 0.0
50-Day Moving Average 9.7062
20-Day Moving Average 8.5745
10-Day Moving Average 8.597
Average True Range 0.7411
ADX 25.74
+DI 13.2236
-DI 57.4297
Chandelier Exit (Long, 3 ATRs ) 7.5467
Chandelier Exit (Short, 3 ATRs ) 7.3433
Upper Bollinger Band 9.5508
Lower Bollinger Band 7.5982
Percent B (%b) 0.0
BandWidth 22.772173
MACD Line -0.2361
MACD Signal Line -0.1328
MACD Histogram -0.1033
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.3950
Resistance 3 (R3) 10.9900 9.3200 10.7625
Resistance 2 (R2) 9.3200 8.3535 9.5225 10.5515
Resistance 1 (R1) 8.4600 7.7565 8.8900 8.8650 10.3407
Pivot Point 6.7900 6.7900 7.0050 6.9925 6.7900
Support 1 (S1) 5.9300 5.8235 6.3600 6.3350 4.8593
Support 2 (S2) 4.2600 5.2265 4.4625 4.6485
Support 3 (S3) 3.4000 4.2600 4.4375
Support 4 (S4) 3.8050